Related references
Note: Only part of the references are listed.TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision
Zeyu Chen et al.
IMMUNITY (2019)
IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses
Rosa M. Santana Carrero et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer
Erminia Massarelli et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
Sylvain Simon et al.
ONCOIMMUNOLOGY (2018)
CD103+CD8+ T lymphocytes in non-small cell lung cancer are phenotypically and functionally primed to respond to PD-1 blockade
Peiliang Wang et al.
CELLULAR IMMUNOLOGY (2018)
T-bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1
Jiang Zhang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
John M. Wrangle et al.
LANCET ONCOLOGY (2018)
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
Daniela S. Thommen et al.
NATURE MEDICINE (2018)
TCF1 expression marks self-renewing human CD8+ T cells
Radomir Kratchmarov et al.
BLOOD ADVANCES (2018)
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C. Huang et al.
NATURE (2017)
Proliferation of PD-1+CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients
Alice O. Kamphorst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma
Juan Fang et al.
BMC CANCER (2017)
Cell-Cycle Regulation Accounts for Variability in Ki-67 Expression Levels
Michal Sobecki et al.
CANCER RESEARCH (2017)
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients
Edwin R. Parra et al.
CLINICAL CANCER RESEARCH (2016)
IL-15 boosts the function and migration of human terminally differentiated CD8+ T cells by inducing a unique gene signature
Ruka Setoguchi
INTERNATIONAL IMMUNOLOGY (2016)
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
Alena Gros et al.
NATURE MEDICINE (2016)
CD8+ T Lymphocyte Self-Renewal during Effector Cell Determination
Wen-Hsuan W. Lin et al.
CELL REPORTS (2016)
Tumor-infiltrating lymphocytes are dynamically desensitized to antigen but are maintained by homeostatic cytokine
Bijan Boldajipour et al.
JCI INSIGHT (2016)
Inflammatory IL-15 is required for optimal memory T cell responses
Martin J. Richer et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Effective effector generation of CD8+ T cells and NK cells: A need for T-bet and ZEB-too
Sara E. Hamilton et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Overcoming T cell exhaustion in infection and cancer
Kristen E. Pauken et al.
TRENDS IN IMMUNOLOGY (2015)
Checkpoint Blockade Immunotherapy Relies on T-bet but Not Eomes to Induce Effector Function in Tumor-Infiltrating CD8+ T Cells
Melissa M. Berrien-Elliott et al.
CANCER IMMUNOLOGY RESEARCH (2015)
PD-1+ CD8+ T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients
X. Wu et al.
BRITISH JOURNAL OF CANCER (2014)
From Truly Naive to Exhausted Senescent T Cells: When Markers Predict Functionality
Anis Larbi et al.
CYTOMETRY PART A (2014)
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
Alena Gros et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients
Bernhard Mlecnik et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
The who's who of T-cell differentiation: Human memory T-cell subsets
Yolanda D. Mahnke et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Detection and Characterization of a Novel Subset of CD8+CD57+ T Cells in Metastatic Melanoma with an Incompletely Differentiated Phenotype
Richard C. Wu et al.
CLINICAL CANCER RESEARCH (2012)
Cutting Edge: Virus-Specific CD8+ T Cell Clones and the Maintenance of Replicative Function during a Persistent Viral Infection
Oliver Bannard et al.
JOURNAL OF IMMUNOLOGY (2010)
Cutting Edge: The Transcription Factor Eomesodermin Enables CD8+ T Cells To Compete for the Memory Cell Niche
Arnob Banerjee et al.
JOURNAL OF IMMUNOLOGY (2010)
CD57(+) T lymphocytes and functional immune deficiency
Daniele Focosi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms
Enrico Ruffini et al.
ANNALS OF THORACIC SURGERY (2009)
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Shawn D. Blackburn et al.
NATURE IMMUNOLOGY (2009)
Phenotype and Function of Human T Lymphocyte Subsets: Consensus and Issues
Victor Appay et al.
CYTOMETRY PART A (2008)
Prognostic value of CD57+ T lymphocytes in the peripheral blood of patients with advanced gastric cancer
Junji Akagi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection
David G. Brooks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells
Andrew M. Intlekofer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Incomplete differentiation of antigen-specific CD8 T cells in tumor-draining lymph nodes
Kristian M. Hargadon et al.
JOURNAL OF IMMUNOLOGY (2006)
High cytotoxic and specific migratory potencies of senescent CD8+CD57+ cells in HIV-infected and uninfected individuals
Yannick Le Priol et al.
JOURNAL OF IMMUNOLOGY (2006)
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
AM Intlekofer et al.
NATURE IMMUNOLOGY (2005)
Control of effector CD8+ T cell function by the transcription factor Eomesodermin
EL Pearce et al.
SCIENCE (2003)
IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells
YM Mueller et al.
INTERNATIONAL IMMUNOLOGY (2003)
IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells
KB Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
